CM
VNDA icon

Caption Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Caption Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,067
Closed -$121K – 2091
2025
Q3 		$110K Sell
22,067
-162,419
-88% -$752K ﹤0.01% 1524
2025
Q2 		$871K Buy
184,486
+106,103
+135% +$464K 0.01% 974
2025
Q1 		$360K Buy
+78,383
New +$365K ﹤0.01% 1173
2022
Q1 		– Sell
-35,317
Closed -$554K – 1981
2021
Q4 		$554K Buy
+35,317
New +$615K 0.01% 1227
2020
Q2 		– Sell
-32,000
Closed -$332K – 1196
2020
Q1 		$332K Buy
32,000
+18,000
+129% +$223K 0.02% 622
2019
Q4 		$230K Buy
+14,000
New +$212K 0.01% 711

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caption Management's VNDA Position: Q4 2025 in Review

Caption Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2025, closing a stake of 22,067 shares — an estimated $121K sold.

Caption Management first reported a position in VNDA in Q4 2019 and held it in 6 quarters. The position peaked at $871K in Q2 2025. 153 funds tracked by Wall St. Rank hold VNDA as of Q4 2025.

  • Caption Management reported no remaining Vanda Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 22,067 Vanda Pharmaceuticals shares in Q4 2025, an estimated $121K.
  • Caption Management first reported a position in Vanda Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • Caption Management's Vanda Pharmaceuticals position peaked at $871K in Q2 2025.
  • 153 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.